This article was featured on NPTA. It sure would be great if the FDA would allow this research to go quickly to start testing on humans!
New Therapy Could Help Treat Terminal Cancer
A promising therapy developed by researchers at the California Pacific Medical Center Research Institute in San Francisco could become a treatment option for patients suffering from advanced stage, terminal cancer.
The researchers have developed an antibody to a molecule called platelet endothelial cell adhesion-1 (PECAM-1), which regulates the proteins that feed cancer when it has reached its final, most lethal stage. The antibody successfully blocked PECAM-1 from fueling metastatic cancer growth, and it improved the health of mice with terminal cancer.
Answer by MaryWolfe at 6:20 AM on Oct. 7, 2010
Answer by Scuba at 7:11 AM on Oct. 7, 2010